Autism Gene Therapy Trial Reaches Patients as US Primate Labs Cede Ground to China
· techtimes.com · popularity 19/100 · 0 similar stories today · Genetics, Genomics & Biotech (Science)
Read the original at techtimes.com →
Summary
Autism gene therapy trial JAG201 is enrolling children ages 2-9 with confirmed SHANK3 gene mutations at US medical centers -- the same macaque primate research infrastructure that enabled JAG201's development is now being dismantled under DOGE pressure, as China commits $743 million to build competing primate neuroscience labs.
Found in: Tech Times. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 9.